Abstract
Objective: Insulinoma causes fasting hypoglycaemia due to inappropriate insulin secretion. The
diagnosis of insulinoma is based on Whipple's triad during a supervised fasting test.
The aim of our study was to evaluate retrospectively the percentage of positive 48-hour
fasting tests in a large series of patients with insulinoma.
Design, Patients and Methods: In a retrospective study, we identified 39 patients (24 females, 15 men; average
age 47 years [range 12-78 years]) with insulinoma. Sixteen patients were diagnosed
by spontaneous hypoglycaemia. Twenty-three patients with insulinoma were tested with
a 48-hour fasting test and compared to 31 healthy controls who had a negative fasting
test and were followed up for at least two years.
Results: The fast was terminated due to neuroglycopenic symptoms in 4 patients (17.4%) at
the 12th hour, in 17 patients (73.9%) at the 24th hour, and in 22 patients (95.7%)
at the 48th hour. One patient with insulinoma had no neuroglycopenic symptoms, but
was diagnosed by glucose and insulin levels during the 48-hour fast. Healthy controls
had significantly higher blood glucose and lower insulin levels, and a lower insulin-glucose
ratio than patients with insulinoma at the end of the fast.
Conclusions: In conclusion, the 48-hour fasting test was successful in the diagnosis of insulinoma
in 95.7% of patients. In this series we did not observe a need for fasting beyond
48 hours.
Key words
Insulinoma - glucose - insulin - neuroendocrine tumour - diagnosis - MEN - fasting
test
References
1
Service FJ, Natt N.
The prolonged fast.
J Clin Endocrinol Metab.
2000;
85
3973-3974
2
Service FJ, Dale AJ, Elveback LR, Jiang NS.
Insulinoma: clinical and diagnostic features of 60 consecutive cases.
Mayo Clin Proc.
1976;
51
417-429
3
Hirshberg B, Livi A, Bartlett DL, Libutti SK, Alexander HR, Doppman JL, Skarulis MC,
Gorden P.
Forty-eight-hour fast: the diagnostic test for insulinoma.
J Clin Endocrinol Metab.
2000;
85
3222-3226
4
Sawicki PT, Heinemann L, Starke A, Berger M.
Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma.
Diabetologia.
1992;
35
649-652
5
Skillern PG, Rynearson EH.
Medical aspects of hypoglycemia.
J Clin Endocrinol Metab.
1953;
13
587-603
6
Breidahl HD, Priestley JT, Rynearson EH.
Hyperinsulinism: surgical aspects and results.
Ann Surg.
1955;
142
698-706
7
Laroche GP, Erris DO, Priestley JT, Scholz DA, Dockerty MB.
Hyperinsulinism. Surgical results and management of occult functioning islet cell
tumor: review of 154 cases.
Arch Surg.
1968;
96
763-772
8
Fendrich V, Bartsch DK, Langer P, Zielke A, Rothmund M.
Diagnosis and surgical treatment of insulinoma-experiences in 40 cases.
Dtsch Med Wochenschr.
2004;
129
941-946
9
Dizon AM, Kowalyk S, Hoogwerf BJ.
Neuroglycopenic and other symptoms in patients with insulinomas.
Am J Med.
1999;
106
307-310
10
Wiesli P, Schmid C, Perren A, Pfammatter T, Spinas GA, Keller U.
Hypoglycemia in response to glucose and glucagon in insulinoma patients with a negative
prolonged fast: functional and morphological properties.
J Endocrinol Invest.
2004;
27
832-838
11
Doppman JL, Chang R, Fraker DL, Norton JA, Alexander HR, Miller DL, Collier E, Skarulis MC,
Gorden P.
Localization of insulinomas to regions of the pancreas by intra-arterial stimulation
with calcium.
Ann Intern Med.
1995;
123
269-273
12
Pasieka JL, MacLeod MK, Thompson NW, Burney RE.
Surgical approach to insulinomas. Assessing the need for preoperative localization.
Arch Surg.
1992;
127
442-447
13
Finlayson E, Clark OH.
Surgical treatment of insulinomas.
Surg Clin North Am.
2004;
84
775-785
14
Grant CS.
Surgical aspects of hyperinsulinemic hypoglycemia.
Endocrinol Metab Clin North Am.
1999;
28
533-554
15
Grant CS.
Insulinoma.
Best Pract Res Clin Gastroenterol.
2005;
19
783-798
16
Wiesli P, Brandle M, Pfammatter T, Zapf J, Spinas GA, Schmid C.
Insulin determination by specific and unspecific immunoassays in patients with insulinoma
evaluated by the arterial stimulation and venous sampling test.
Eur J Endocrinol.
2004;
151
123-126
17
Gorden P, Skarulis MC, Roach P, Comi RJ, Fraker DL, Norton JA, Alexander HR, Doppman JL.
Plasma proinsulin-like component in insulinoma: a 25-year experience.
J Clin Endocrinol Metab.
1995;
80
2884-2887
18
Shimizu T, Sasakuma F, Ishikawa O, Matsumiya K, Hasegawa K, Sasaki A.
Assessment of immunoassays for insulin in diagnostic tests for insulinoma.
Diabetes Res Clin Pract.
1994;
26
149-154
19
Gama R, Teale JD, Marks V.
Best practice No 173: clinical and laboratory investigation of adult spontaneous hypoglycaemia.
J Clin Pathol.
2003;
56
641-646
Correspondence
M. QuinklerMD
Clinical Endocrinology
Internal Medicine Centre for Gastroenterology, Hepatology, and Endocrinology
Charité Campus Mitte
Charitéplatz 1
10117 Berlin
Germany
Phone: +49/30/45051 41 52
Fax: +49/30/45051 49 52
Email: marcus.quinkler@charite.de